Lymphedema Treatment Act
Latest action · Nov 17, 2022 Received in the Senate and Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 28, 2021
- Passed HouseNov 17, 2022
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Lymphedema Treatment Act
This bill provides for Medicare coverage of lymphedema compression treatment items. Specifically, the bill provides for coverage of standard and custom fitted gradient compression garments and other approved items that are prescribed by a physician or other specified health care professional to treat lymphedema.
Recorded votes 1
Newest first. Open one to see how every member voted.
| Roll call | Question | Result | Date |
|---|---|---|---|
| House 485 | On Motion to Suspend the Rules and Pass, as Amended | Passed402–13 | Nov 17, 2022 |
Cosponsors 356
Members who signed on, in the order they did. Signatures ran from May 28, 2021 to Jul 12, 2022; 147 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-GA | A. Drew Ferguson IV | Original | May 28, 2021 |
| D-WA | Adam Smith | Original | May 28, 2021 |
| D-NJ | Albio Sires | Original | May 28, 2021 |
| D-NC | Alma S. Adams | Original | May 28, 2021 |
| D-CA | Ami Bera | Original | May 28, 2021 |
| D-IN | André Carson | Original | May 28, 2021 |
| D-MI | Andy Levin | Original | May 28, 2021 |
| D-AZ | Ann Kirkpatrick | Original | May 28, 2021 |
| D-MD | Anthony G. Brown | Original | May 28, 2021 |
| D-NY | Antonio Delgado | Original | May 28, 2021 |
| R-GA | Austin Scott | Original | May 28, 2021 |
| D-MA | Ayanna Pressley | Original | May 28, 2021 |
| D-CA | Barbara Lee | Original | May 28, 2021 |
| D-MS | Bennie G. Thompson | Original | May 28, 2021 |
| R-TX | Beth Van Duyne | Original | May 28, 2021 |
Withdrew 1 Scott Perry R-PA Mar 30, 2022
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 28, 2021Markup Jul 13, 2022Reported Jul 22, 2022 |
| Health Subcommittee | Referred May 31, 2021Discharged Jul 12, 2022 | |
| House | Ways and Means Committee | Referred May 28, 2021Discharged Jul 22, 2022 |
| Senate | Finance Committee | Referred Nov 17, 2022 |
Actions 18
Everything that happened, newest first.
- Nov 17, 2022Considered as unfinished business. (consideration: CR H8576-8577)
- Nov 17, 2022Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 13 (Roll no. 485). (text: 11/14/2022 CR H8469)
- Nov 17, 2022Motion to reconsider laid on the table Agreed to without objection.
- Nov 17, 2022Received in the Senate and Read twice and referred to the Committee on Finance.
- Nov 14, 2022Mr. Pallone moved to suspend the rules and pass the bill, as amended.
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Extensions | Debate and remarks E1215 | Paul Tonko D-NY | Dec 5, 2022 |
| House | Recorded votes H8576enactLists H8577Votes recorded by proxy on H.R. 3630, Lymphedema Treatment Act | — | Nov 17, 2022 |
| House | Debate and remarks H8469–H8471Text printed H8469 | Frank Pallone, Jr. D-NJ, Gus M. Bilirakis R-FL, Janice D. Schakowsky D-IL | Nov 14, 2022 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Sep 23, 2022H.R. 3630, Lymphedema Treatment ActAs ordered reported by the House Committee on Energy and Commerce on July 13, 2022
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 94, May 28, 2021, page H2680.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R47625 | The House Consensus Calendar: Principal Features and Practice in the 117th Congress (2021-2022) | Report | Jul 13, 2023 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1315 | Lymphedema Treatment Act | Identical bill | Apr 22, 2021 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to provide for coverage of certain lymphedema compression treatment items under the Medicare program.
- Short Title(s) as Introduced
- Lymphedema Treatment Act
- Short Title(s) as Reported to House
- Lymphedema Treatment Act
- Short Title(s) as Passed House
- Lymphedema Treatment Act
- Short Titles from RFS (Referred to Senate) bill text
- Lymphedema Treatment Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Nov 17, 2022Referred in Senate
- Nov 17, 2022Engrossed in House
- Jul 22, 2022Reported in House
- May 28, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.